EUREKA THERAPEUTICS, INC. enters ESTRELLA IMMUNOPHARMA, INC. with 25.28M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 10/10/2023ACC: 0001013762-23-002838
10% Owner
Since Sep 2023
25.28M
Baseline shares
100% direct
25.28M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned25.28M
Total
25.28M direct25.28M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.28M | Direct |
| Total | 25.28M | 25.28M direct |
Derivative Holdings0
No derivative holdings reported